MedPath

A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Phase 2
Active, not recruiting
Conditions
Geographic Atrophy
Interventions
Registration Number
NCT05811351
Lead Sponsor
Janssen Research & Development, LLC
Brief Summary

The purpose of this study is to evaluate change in geographic atrophy (GA) lesion growth of eyes treated with JNJ-81201887 compared to sham control.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
305
Inclusion Criteria
  • Have non-subfoveal (defined as not involving the center point of the fovea) geographic atrophy (GA) secondary to age-related macular degeneration (AMD) with an area that can be measured and measures 2.5 millimeter square (mm^2) to 17.5 mm^2 (1- and 7- disc areas respectively), determined by the central reading center (CRC) from screening images of fundus autofluorescence (FAF) and spectral domain optical coherence tomography (SD-OCT)
  • If GA is multifocal, at least one focal lesion must be greater than or equal to (>=) 1.25 mm^2 (0.5- disc area), as assessed by the CRC
  • GA can be photographed in its entirety by FAF, using a 30- degree image centered on the fovea, as assessed by the CRC
  • Fellow eye must be present with a best corrected distance visual acuity (BCVA) of counting fingers or better
  • Man or woman (according to their reproductive organs and functions assigned by chromosomal complement)
Exclusion Criteria
  • History of transpupillary thermotherapy, photodynamic therapy or external-beam radiation therapy in the region of study eye
  • Any prior thermal laser in the macular region, regardless of indication
  • History of retinal detachment (with or without repair)
  • Active, infectious conjunctivitis, keratitis, scleritis, or endophthalmitis
  • Any sign of diabetic retinopathy or central serous chorioretinopathy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm A: JNJ-81201887 Low DoseJNJ-81201887Participants will receive a single low dose intravitreal injection of JNJ-81201887 in the study eye on Day 4. In addition, participants will receive a 20-day oral prednisone course starting on Day 1 and a single, long acting periocular triamcinolone (corticosteroid injection) on Day 4 for prophylaxis of intraocular inflammation.
Arm A: JNJ-81201887 Low DosePrednisoneParticipants will receive a single low dose intravitreal injection of JNJ-81201887 in the study eye on Day 4. In addition, participants will receive a 20-day oral prednisone course starting on Day 1 and a single, long acting periocular triamcinolone (corticosteroid injection) on Day 4 for prophylaxis of intraocular inflammation.
Arm A: JNJ-81201887 Low DoseTriamcinoloneParticipants will receive a single low dose intravitreal injection of JNJ-81201887 in the study eye on Day 4. In addition, participants will receive a 20-day oral prednisone course starting on Day 1 and a single, long acting periocular triamcinolone (corticosteroid injection) on Day 4 for prophylaxis of intraocular inflammation.
Arm B: JNJ-81201887 High doseJNJ-81201887Participants will receive a single high dose intravitreal injection of JNJ-81201887 in the study eye on Day 4. In addition, participants will receive a 20-day oral prednisone course starting on Day 1 and a single, long acting periocular triamcinolone (corticosteroid injection) on Day 4 for prophylaxis of intraocular inflammation.
Arm B: JNJ-81201887 High dosePrednisoneParticipants will receive a single high dose intravitreal injection of JNJ-81201887 in the study eye on Day 4. In addition, participants will receive a 20-day oral prednisone course starting on Day 1 and a single, long acting periocular triamcinolone (corticosteroid injection) on Day 4 for prophylaxis of intraocular inflammation.
Arm B: JNJ-81201887 High doseTriamcinoloneParticipants will receive a single high dose intravitreal injection of JNJ-81201887 in the study eye on Day 4. In addition, participants will receive a 20-day oral prednisone course starting on Day 1 and a single, long acting periocular triamcinolone (corticosteroid injection) on Day 4 for prophylaxis of intraocular inflammation.
Arm C: Sham ProcedurePlaceboParticipants will receive sham procedure that matches the single JNJ21801887 injection on Day 4, a sham procedure that matches the long acting periocular triamcinolone (corticosteroid injection) on Day 4 and a 20-day placebo matching oral prednisone starting on Day 1.
Arm C: Sham ProcedureSham ProcedureParticipants will receive sham procedure that matches the single JNJ21801887 injection on Day 4, a sham procedure that matches the long acting periocular triamcinolone (corticosteroid injection) on Day 4 and a 20-day placebo matching oral prednisone starting on Day 1.
Primary Outcome Measures
NameTimeMethod
Global: Change From Baseline in Square Root of Geographic Atrophy (GA) Lesion Area in the Study Eye at Month 18Baseline and Month 18

Change from baseline in GA lesion area in the study at month 18 eye will be measured via retinal imaging using fundus auto fluorescence (FAF).

United States (U.S.) Specific: Rate of Change in Untransformed GA Lesion Area in the Study EyeBaseline to Month 18

Rate of Change in untransformed GA lesion area in the study eye will be measured via retinal imaging using FAF. A piecewise linear mixed effects (PLME) model will be used for the primary efficacy analysis for rate of change in GA area (GAA) in the study eye.

Secondary Outcome Measures
NameTimeMethod
Change From Baseline in Retinal Sensitivity by Mesopic Microperimetry (MAIA) at Month 18Baseline and Month 18

Change from baseline retinal sensitivity by MAIA will be reported.

Change From Baseline in Best Corrected Visual Acuity (BCVA) at Month 18Baseline and Month 18

Change from baseline in BCVA will be reported and this will be measured using the ETDRS chart at a starting distance of 4 meter.

Change From Baseline in Reading Speed at Month 18Baseline and Month 18

Change from baseline in reading speed (normal luminance) as assessed by Radner reading charts will be performed in the study eye and binocularly for participants who are fluent in the languages available for the Radner Chart will be reported.

Change From Baseline in Low Luminance Visual Acuity (LLVA) at Month 18Baseline and Month 18

Best corrected LLVA will be assessed using the early treatment diabetic retinopathy study (ETDRS) chart at a starting distance of 4 meter.

Change From Baseline in National Eye Institute Visual Functioning Questionnaire-25 (NEI-VFQ-25) Composite Score at Month 18Baseline and Month 18

The 2000 version of the NEI-VFQ-25, which must be interviewer-administered, includes 25 items and is scored to produce 11 subscales and a general health item. The 11 subscales include General Vision (1 item), Ocular Pain (2 items), Near Activities (3 items), Distance Activities (3 items), Social Functioning (2 items), Mental Health (2 items), Role Difficulties (2 items), Dependency (3 items), Driving (3 items), Color Vision (1 item), and Peripheral Vision (1 item). Response to each question converted to 0-100 score. Each subscale, total score equal to (=) average of items contributing to score. For each subscale and total score, score range: 0 to 100, higher score equal to less symptoms/better visual functioning.

Change From Baseline in Functional Reading Independence (FRI) Index at Month 18Baseline and Month 18

The FRI is an interviewer-administered questionnaire with 7 items on functional reading activities most relevant to GA AMD participants. Item scores reflect decreasing levels of functional reading independence. The FRI Index yields continuous mean scores (range 1 to 4), and ordinal-level scores from Level 1 = "Unable to do" to Level 4 = "Totally independent." For each FRI Index reading activity performed in the past 7 days, participants are asked about the extent to which they required vision aids, adjustments in the activity, or help from another person.

Trial Locations

Locations (159)

Medizinische Hochschule Hannover

🇩🇪

Hannover, Germany

Universitatsklinikum Schleswig Holstein Kiel

🇩🇪

Kiel, Germany

Universitaetsklinikum Leipzig

🇩🇪

Leipzig, Germany

Klinikum Ludwigshafen

🇩🇪

Ludwigshafen am Rhein, Germany

Augenzentrum am St Franziskus Hospital Munster

🇩🇪

Muenster, Germany

Universitaetsklinikum Muenster

🇩🇪

Muenster, Germany

Universitaetsklinikum Tuebingen

🇩🇪

Tuebingen, Germany

Eszak Pesti Centrumkorhaz Honvedkorhaz

🇭🇺

Budapest, Hungary

Ganglion Orvosi Központ

🇭🇺

Pecs, Hungary

Zala Megyei Szent Rafael Korhaz

🇭🇺

Zalaegerszeg, Hungary

Arcispedale S. Anna Ferrara

🇮🇹

Ferrara, Italy

Fondazione IRCCS Ca Granda Ospedale Policlinico Di Milano

🇮🇹

Milano, Italy

Ospedale San Raffaele

🇮🇹

Milano, Italy

Sacco Hospital

🇮🇹

Milano, Italy

Baskent University Ankara Hospital

🇹🇷

Ankara, Turkey

Ankara Bilkent Sehir Hastanesi

🇹🇷

Ankara, Turkey

Dokuz Eylul University Hospital

🇹🇷

İzmir, Turkey

Konya Selcuk University Medical Faculty

🇹🇷

Konya, Turkey

Bristol Eye Hospital

🇬🇧

Bristol, United Kingdom

Azienda Ospedaliera Univ.- Università Degli studi della Campania - Luigi Vanvitelli

🇮🇹

Napoli, Italy

Policlinico Universitario Agostino Gemelli

🇮🇹

Roma, Italy

Amsterdam University Medical Centers Location Academic Medical Center

🇳🇱

Amsterdam, Netherlands

Het Oogziekenhuis Rotterdam

🇳🇱

Rotterdam, Netherlands

Oculomedica

🇵🇱

Bydgoszcz, Poland

Oftalmika

🇵🇱

Bydgoszcz, Poland

Uno Med

🇵🇱

Tarnow, Poland

Warszawski Szpital Okulistyczny

🇵🇱

Warszawa, Poland

Uls Coimbra - Hosp. Univ. Coimbra

🇵🇹

Coimbra, Portugal

Espaco Medico de Coimbra

🇵🇹

Coimbra, Portugal

Uls Sao Joao - Hosp. Sao Joao

🇵🇹

Porto, Portugal

Centro de Oftalmologia Barraquer

🇪🇸

Barcelona, Spain

Centro Medico Teknon S.L.

🇪🇸

Barcelona, Spain

Inst. Cat. de Retina

🇪🇸

Barcelona, Spain

Hosp. Dos de Maig

🇪🇸

Barcelona, Spain

Inst. de Microcirugia Ocular

🇪🇸

Barcelona, Spain

Clinica Oftalvist Valencia

🇪🇸

Burjassot, Spain

Hosp. La Arruzafa

🇪🇸

Cordoba, Spain

Hosp. Univ. Donostia

🇪🇸

Donostia San Sebastian, Spain

Hosp Univ Fund Jimenez Diaz

🇪🇸

Madrid, Spain

Hosp. Univ. 12 de Octubre

🇪🇸

Madrid, Spain

Clinica Baviera Madrid Castellana

🇪🇸

Madrid, Spain

Hosp. Univ. Pta. de Hierro Majadahonda

🇪🇸

Majadahonda, Spain

Clinica Univ. de Navarra

🇪🇸

Pamplona, Spain

Idc Salud Hosp. Gral. de Catalunya

🇪🇸

Sant Cugat del Valles, Spain

Hosp. Prov. Do Conxo

🇪🇸

Santiago de Compostela, Spain

Hosp. Virgen Del Rocio

🇪🇸

Sevilla, Spain

Hosp. Clinico Univ. Lozano Blesa

🇪🇸

Zaragoza, Spain

Hosp. Univ. Miguel Servet

🇪🇸

Zaragoza, Spain

S:t Eriks Ogonsjukhus

🇸🇪

Stockholm, Sweden

Inselspital Universitatsspital Bern

🇨🇭

Bern, Switzerland

Hacettepe University Hospital

🇹🇷

Ankara, Turkey

Moorfields Eye Hospital

🇬🇧

London, United Kingdom

Central Middlesex Hospital

🇬🇧

London, United Kingdom

The Retina Clinic London

🇬🇧

London, United Kingdom

Manchester Royal Eye Hospital

🇬🇧

Manchester, United Kingdom

Royal Victoria Infirmary

🇬🇧

Newcastle upon Tyne, United Kingdom

Oxford Eye Hospital

🇬🇧

Oxford, United Kingdom

Southampton University Hospital

🇬🇧

Southampton, United Kingdom

AXON Clinical s.r.o.

🇨🇿

Prague, Czechia

Fakultni nemocnice Kralovske Vinohrady

🇨🇿

Praha 10, Czechia

Retinal Research Institute

🇺🇸

Phoenix, Arizona, United States

Retina Associates Southwest PC

🇺🇸

Tucson, Arizona, United States

Retina Consultants of Orange County

🇺🇸

Fullerton, California, United States

Retina Associates Of Southern California

🇺🇸

Huntington Beach, California, United States

Shiley Eye Institute Jacobs Retina Center

🇺🇸

La Jolla, California, United States

Jules Stein Eye Institute UCLA

🇺🇸

Los Angeles, California, United States

The Retina Partners

🇺🇸

Los Angeles, California, United States

California Retina Consultants

🇺🇸

Oxnard, California, United States

Stanford Health Care

🇺🇸

Palo Alto, California, United States

California Eye Medical Specialists

🇺🇸

Pasadena, California, United States

Retina Consultants San Diego

🇺🇸

Poway, California, United States

Retina Consultants of Southern California

🇺🇸

Redlands, California, United States

Bay Area Retina Associates

🇺🇸

Walnut Creek, California, United States

Colorado Retina - Lakewood Clinic

🇺🇸

Lakewood, Colorado, United States

Retina Group of Florida

🇺🇸

Fort Lauderdale, Florida, United States

National Opthalmic Research Institute

🇺🇸

Fort Myers, Florida, United States

VitreoRetinal Associates, PA

🇺🇸

Gainesville, Florida, United States

MedEye Associates

🇺🇸

Miami, Florida, United States

Retina Specialty Institute

🇺🇸

Pensacola, Florida, United States

Fort Lauderdale Eye Institute

🇺🇸

Plantation, Florida, United States

Retina Vitreous Associates of Florida

🇺🇸

Saint Petersburg, Florida, United States

East Florida Eye Institute

🇺🇸

Stuart, Florida, United States

Georgia Retina

🇺🇸

Marietta, Georgia, United States

Marietta Eye Clinic

🇺🇸

Marietta, Georgia, United States

University Of Illinois

🇺🇸

Chicago, Illinois, United States

Retina Associates

🇺🇸

Elmhurst, Illinois, United States

University Retina

🇺🇸

Lemont, Illinois, United States

Midwest Eye Institute

🇺🇸

Carmel, Indiana, United States

Maine Eye Center

🇺🇸

Portland, Maine, United States

Retina Specialists

🇺🇸

Baltimore, Maryland, United States

The Retina Care Center

🇺🇸

Baltimore, Maryland, United States

The Retina Group of Washington

🇺🇸

Chevy Chase, Maryland, United States

Cumberland Valley Retina Consultants

🇺🇸

Hagerstown, Maryland, United States

Ophthalmic Consultants of Boston

🇺🇸

Boston, Massachusetts, United States

Vitreo Retinal Associates-Worcester

🇺🇸

Worcester, Massachusetts, United States

Foundation for Vision Research

🇺🇸

Grand Rapids, Michigan, United States

Associated Retinal Consultants P.C.

🇺🇸

Royal Oak, Michigan, United States

Retina Consultants of Minnesota

🇺🇸

Saint Louis Park, Minnesota, United States

The Retina Institute

🇺🇸

Saint Louis, Missouri, United States

Sierra Eye Associates

🇺🇸

Reno, Nevada, United States

Wills Eye/Mid Atlantic Retina

🇺🇸

Cherry Hill, New Jersey, United States

Long Island Vitreo Retinal Consultants

🇺🇸

Great Neck, New York, United States

Retina-Vitreous Surgeons of Central New York

🇺🇸

Liverpool, New York, United States

Vitreous Retina Macula Consultants of New York

🇺🇸

New York, New York, United States

Retina Consultants PLLC

🇺🇸

Slingerlands, New York, United States

Opthalmic Consultants of the Capital Region

🇺🇸

Troy, New York, United States

Asheville Eye Associates - Western Carolina Retinal Associates

🇺🇸

Asheville, North Carolina, United States

Duke University

🇺🇸

Durham, North Carolina, United States

Graystone Eye

🇺🇸

Hickory, North Carolina, United States

NC Retina Associates

🇺🇸

Wake Forest, North Carolina, United States

Cincinnati Eye Institute

🇺🇸

Cincinnati, Ohio, United States

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

Verum Research LLC

🇺🇸

Eugene, Oregon, United States

Casey Eye Institute

🇺🇸

Portland, Oregon, United States

Cascade Medical Research Institute, LLC

🇺🇸

Springfield, Oregon, United States

Erie Retina Research

🇺🇸

Erie, Pennsylvania, United States

Charleston Neuroscience Institute, LLC

🇺🇸

Beaufort, South Carolina, United States

Charles Retina Institute

🇺🇸

Germantown, Tennessee, United States

Retina Research Institute of Texas

🇺🇸

Abilene, Texas, United States

Panhandle Eye Group LLP-Southwest Retina Specialists

🇺🇸

Amarillo, Texas, United States

Austin Clinical Research

🇺🇸

Austin, Texas, United States

Retina and Vitreous of Texas, PLLC

🇺🇸

Bellaire, Texas, United States

Retina Consultants of Texas

🇺🇸

The Woodlands, Texas, United States

Retina Foundation of the Southwest

🇺🇸

Dallas, Texas, United States

Texas Retina Associates

🇺🇸

Fort Worth, Texas, United States

UT Southwestern

🇺🇸

Dallas, Texas, United States

Houston Eye Associates

🇺🇸

Houston, Texas, United States

San Antonio Eye Center

🇺🇸

San Antonio, Texas, United States

Retina Associates Of South Texas P A

🇺🇸

San Antonio, Texas, United States

Strategic Clinical Research Group

🇺🇸

Willow Park, Texas, United States

Retina Associates of Utah P C

🇺🇸

Salt Lake City, Utah, United States

Rocky Mountain Retina Consultants

🇺🇸

Salt Lake City, Utah, United States

University of Utah

🇺🇸

Salt Lake City, Utah, United States

Piedmont Eye Center

🇺🇸

Lynchburg, Virginia, United States

Wagner Kapoor Research institute

🇺🇸

Norfolk, Virginia, United States

Spokane Eye Clinical Research

🇺🇸

Spokane, Washington, United States

Adelaide Eye and Retina Centre

🇦🇺

Adelaide, Australia

Centre for Eye Research Australia

🇦🇺

East Melbourne, Australia

Strathfield Retina Clinic

🇦🇺

Strathfield, Australia

Sydney Retina Clinic and Day Surgery

🇦🇺

Sydney, Australia

Sydney West Retina

🇦🇺

Westmead, Australia

Ziekenhuis Oost-Limburg

🇧🇪

Genk, Belgium

UZ Gent

🇧🇪

Gent, Belgium

UZ Leuven Gasthuisberg

🇧🇪

Leuven, Belgium

Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman

🇧🇪

Liege, Belgium

Calgary Retina Consultants

🇨🇦

Calgary, Alberta, Canada

Alberta Retina Consultants

🇨🇦

Edmonton, Alberta, Canada

The Ottawa Hospital Research Institute

🇨🇦

Ottawa, Ontario, Canada

The Retina Centre of Ottawa

🇨🇦

Ottawa, Ontario, Canada

Institut De L'oeil Des Laurentides

🇨🇦

Boisbriand, Quebec, Canada

OFTEX Ltd. - EYE CENTER

🇨🇿

Pardubice, Czechia

Aalborg University Hospital

🇩🇰

Aalborg, Denmark

University Hospital Of Copenhagen, Glostrup Hospital

🇩🇰

Glostrup, Denmark

Zealand University Hospital

🇩🇰

Roskilde, Denmark

Charite Universitaetsmedizin Berlin

🇩🇪

Berlin, Germany

Universitaets-Augenklinik Bonn

🇩🇪

Bonn, Germany

Universitatsklinikum Gießen - Klinik und Poliklinik fur Augenheilkunde

🇩🇪

Giessen, Germany

Klinikum Gottingen der Georg August Universitat

🇩🇪

Gottingen, Germany

Radboudumc

🇳🇱

Nijmegen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath